Parkinson disease trials in France

In France 65 Also abroad 823

65 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Where
Bordeaux, Clermont Ferrand Cedex 1, Creteil Cedex, Marseille, Nice, Paris, Toulouse
Age
40 years to 85 years
People
474 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00
No phaseNot yet taking people in France
Compulsive Eating and Brain's Reward System in Different Pathologies
Where
Clermont-Ferrand
Age
18 years to 80 years
People
150
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT07923513
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Where
Besancon Cedex, Bron, Clermont Ferrand Cedex 1, Creteil Cedex, La Tronche, Lille Cedex, Limoges Cedex 1, Marseille, Montpellier Cedex 5, Nice, Paris, Toulouse
Age
50 years to 85 years
People
900 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00
No phaseTaking people
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Where
Clermont-Ferrand
Age
18 years to 90 years
People
5,000
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT04375280
Phase 3Not yet taking people in France
Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians
Where
Nimes Cedex 9, Toulouse
Age
40 years to 80 years
People
39
Run by
University Hospital, Toulouse
See details and how to joinNCT07822893 · EU 2026-525862-23-00
Phase 2Taking people
Prevent Cognitive Decline in GBA-associated Parkinson's Disease
Where
Paris
Age
35 years to 80 years
People
120 worldwide
Run by
University Hospital Tuebingen
See details and how to joinNCT07055087 · EU 2024-513496-40-00
Phase 2/3Taking people
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Where
Amiens Cedex 1, Besançon, Bordeaux, Bron, Caen, Créteil Cedex, Dijon, Grenoble Cedex 9, Lille, Marseille Cedex 5, Montpellier Cedex 5, Nantes Cedex 1, Nice, Nîmes, Paris, Poitiers, Rennes Cedex 09 France, Rouen, Strasbourg Cedex 2, Toulouse
Age
40 years to 80 years
People
550 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00
Phase 1Taking people
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.
Where
Lille, Paris, Toulouse
Age
18 years to 75 years
People
106 worldwide
Run by
Mission Therapeutics
See details and how to joinNCT07630545 · EU 2024-517310-15-01
No phaseTaking people
Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease
Where
Paris
Age
18 years and over
People
528
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07505394
No phaseNot yet taking people in France
Primary Parkinsonian Pain: Clinical Association and Phenotype
Where
Clermont-Ferrand
Age
18 years and over
People
300
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT07702266
No phaseTaking people
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Where
Créteil, Lyon, Marseille, Paris, Rennes
Age
18 years and over
People
1,500 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT02071134
No phaseTaking people
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Where
Paris
People
5,000 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT03664609
No phaseTaking people
Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis
Where
Dijon
Age
18 years and over
People
66
Run by
Centre Hospitalier Universitaire Dijon
See details and how to joinNCT06439355
No phaseTaking people
Enabling Women With Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms
Where
Grenoble, Nantes, Rennes, Toulouse
Age
18 years to 56 years
People
100
Run by
University Hospital, Grenoble
See details and how to joinNCT06582212
No phaseNot yet taking people in France
Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study
Where
Toulouse
Age
50 years and over
People
60 worldwide
Run by
Queen Mary University of London
See details and how to joinNCT07706829
No phaseTaking people
Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease
Where
Grenoble
Age
30 years to 75 years
People
100
Run by
University Hospital, Grenoble
See details and how to joinNCT06701955
No phaseTaking people
The Role of Priors in Hallucinatory Perception in Parkinson's Disease
Where
Grenoble, La Tronche
Age
18 years to 85 years
People
60
Run by
University Hospital, Grenoble
See details and how to joinNCT07427498
No phaseNot yet taking people in France
ANCILLARY STUDY No. 3 NS-PARK-OMICS
Where
Paris
Age
18 years and over
People
80
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07832461
No phaseNot yet taking people in France
Idiopathic Parkinson's Disease: Interest of an Early Group-Based Cognitive Rehabilitation Program (LIFECOG-PD)
Where
Clermont-Ferrand
Age
18 years and over
People
24
Run by
University Hospital, Clermont-Ferrand
See details and how to joinNCT07813156
Phase 2Taking people
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Where
Creteil Cedex, Lille Cedex, Toulouse
Age
40 years to 85 years
People
150 worldwide
Run by
H. Lundbeck A/S
See details and how to joinNCT07514858 · EU 2025-524655-30-00
Phase 2Not yet taking people in France
A Phase 2 study of VQ-101 in participants with Parkinson’s disease and GBA1 mutation
Where
Toulouse
Age
18 years and over
People
16 worldwide
Run by
Vanqua Bio Inc.
See details and how to join2026-525848-15-00 · EU 2026-525848-15-00
No phaseNot yet taking people in France
Sensor-Based Optimization of Therapy for Parkinson's Disease Patients With Motor Fluctuations
Where
Paris
Age
46 years to 83 years
People
218
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07074119
No phaseTaking people
Combined Genome and RNA Sequencing for Genetic Diagnosis of Parkinsonism
Where
Strasbourg
Age
18 years and over
People
14
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT06576713
No phaseTaking people
French Parkinson's Disease Cohort - NS-PARK
Where
Paris
Age
10 years and over
People
30,000
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04888364
No phaseTaking people
In Vivo Noradrenergic System and Aging
Where
Bron
Age
20 years to 80 years
People
165
Run by
Hospices Civils de Lyon
See details and how to joinNCT07569120 · EU 2025-524602-15-00